Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PROCEPT BioRobotics Corporation - Common Stock
(NQ:
PRCT
)
27.32
+0.32 (+1.17%)
Streaming Delayed Price
Updated: 12:39 PM EDT, Jun 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
233,823
Open
27.27
Bid (Size)
27.26 (200)
Ask (Size)
27.37 (100)
Prev. Close
27.00
Today's Range
26.59 - 27.50
52wk Range
19.35 - 66.85
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
May 28, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch
↗
May 23, 2026
Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations.
Via
The Motley Fool
Performance
YTD
-11.2%
-11.2%
1 Month
+8.5%
+8.5%
3 Month
+7.8%
+7.8%
6 Month
-22.9%
-22.9%
1 Year
-55.7%
-55.7%
More News
Read More
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
↗
May 23, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) Q1 Earnings Beat Drives 13% Surge Despite Net Loss
↗
April 29, 2026
Via
Chartmill
Topics
Earnings
5 Robotics Stocks to Watch as Physical AI Builds Momentum
↗
May 18, 2026
Via
MarketBeat
Topics
Artificial Intelligence
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
May 14, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
April 30, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Procept (PRCT) Q1 2026 Earnings Transcript
↗
April 30, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
What's going on in today's after hours session
↗
April 29, 2026
Via
Chartmill
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
April 29, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock
↗
April 24, 2026
Via
The Motley Fool
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
April 22, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
April 22, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
April 22, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
PROCEPT BioRobotics (PRCT) Earnings Transcript
↗
April 14, 2026
Via
The Motley Fool
Topics
World Trade
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
April 09, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
March 24, 2026
From
Pomerantz LLP
Via
GlobeNewswire
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
March 23, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
March 12, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
March 10, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
March 10, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 10, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
March 09, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm
March 08, 2026
From
The Schall Law Firm
Via
Business Wire
Frequently Asked Questions
Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 27.32
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 06/05/26 12:39 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
